MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Microglial activation, white matter and hippocampal damage correlate with cognitive impairment in chronic cerebral hypoperfused and MPTP-lesioned mice

    Y. Gao, H. Tang, K. Nie, R. Zhu, L. Gao, S. Feng, L. Wang, J. Zhao, Z. Huang, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: We hypothesize that cerebral hypoperfusion may influence the cognitive function of PD animal models. To investigate the effects of cerebral hypoperfusion and microangiopathy on…
  • 2018 International Congress

    Investigating the role of microRNA biogenesis pathway in neuroprotection in primary neuronal culture model of Parkinson’s disease

    J. Konovalova, S. Er, S. Soleimanbeigi, P. Chmielarz, A. Domanskyi (Helsinki, Finland)

    Objective: Here we study the effect of microRNAs (miRs) biogenesis on the dopamine (DA) neuronal maintenance and protection from different stressor-induced insults. Background: Despite many…
  • 2018 International Congress

    Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

    I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

    Objective: To test whether machine learning algorithms are suitable to classify dopamine and behavioral states in Parkinson’s patients (PD). Background: While motor symptoms of PD…
  • 2018 International Congress

    The Prevalence of Tandem Gait Abnormality in Parkinson’s Disease

    J. Margolesky, S. Bette, D. Shpiner, T. Rundek, C. Luca, H. Moore, C. Singer (Miami, FL, USA)

    Objective: To assess the prevalence of tandem gait abnormality in patients with Parkinson’s disease (PD), comparing Hoehn and Yahr (HY) stages 2 and 3. Background:…
  • 2018 International Congress

    Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson’s disease

    S. Klanbut, C. Luangsinsiri, N. Piyaparneekul, C. Khongbut, K. Methawasin (Nakhon Nayok, Thailand)

    Objective: To determine the prevalence and risk factors associated with peak-dose dyskinesia in Thai patients with Parkinson’s disease. Background: Dyskinesias are involuntary movement that interfere…
  • 2018 International Congress

    Cortical correlates of dual-task turning with and without freezing of gait

    M. Mancini, S. Stuart (Portland, OR, USA)

    Objective: This study investigated the relationship between prefrontal cortex (PFC) activity and turning characteristics with and without a dual-task in in people with Parkinson’s disease…
  • 2018 International Congress

    Automated immunohistochemical detection of pathological alpha-synuclein in human tissue biopsy

    TS. Tsao, A. Racolta, H. Zhang, M. Robida, J. Pugh, T. Beach, T. Kremer, C. Czech, K. Taylor, W. Zago, L. Pestic-Dragovich, L. Tang, S. Dziadek (Tucson, AZ, USA)

    Objective: The goals of this study were to create a highly sensitive brightfield immunohistochemical (IHC) assay for pathological alpha-synuclein (aSyn) in formalin-fixed, paraffin embedded (FFPE)…
  • 2018 International Congress

    Natural occurring antibodies reduce aggregation of α-synuclein

    A. Braczynski, E. Agerschou, Y. Kronimus, W. Hoyer, R. Dodel, B. Falkenburger, J. Schulz, J. Bach (Aachen, Germany)

    Objective: We tested naturally occurring antibodies (nAbs) against α-synuclein both in vitro as well as in HEK293T cells to determine binding, cell viability and capacity…
  • 2018 International Congress

    Peripheral Inflammatory Mediators in Parkinson’s Disease – A Potential Biomarker

    K. Chatterjee, A. Roy, R. Banerjee, S. Halder, S. Choudhury, P. Basu, S. Shubham, H. Kumar (Kolkata, India)

    Objective: i.To determine if post-translationally modified phosphorylated α-synuclein levels are altered in the peripheral blood of Parkinson’s disease (PD) patients compared to control subjects. ii.To…
  • 2018 International Congress

    A metabolomic signature of treated and drug-naïve patients with Parkinson disease: A pilot study

    J. Troisi, A. Landolfi, C. Vitale, K. Longo, A. Cozzolino, M. Squillante, M.C. Savanelli, P. Barone, M. AmbonI (Salerno, Italy)

    Objective: The aim of our case–control study is to compare entire blood metabolomic profiles obtained from treated PD patients, de novo PD patients and controls,…
  • « Previous Page
  • 1
  • …
  • 1571
  • 1572
  • 1573
  • 1574
  • 1575
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley